Transcutaneous carbon dioxide profile during sleep reveals metabolic risk factors in post-menopausal females

The risks of metabolic syndrome and sleep-disordered breathing increase around the time of the menopause. We have previously shown that features of the nocturnal transcutaneous carbon dioxide (TcCO2) profile are associated with metabolic variables such as cholesterol, glycosylated haemoglobin A1C (GHbA1C) and blood pressure in patients with sleep apnoea. In the present study, we investigated whether these metabolic variables can be predicted using noninvasive TcCO2 measurements during sleep in generally healthy post-menopausal females. 22 post-menopausal females underwent an overnight polygraphic sleep study that involved the continuous monitoring of arterial oxygen saturation (Sa,O2) and TcCO2. Body composition, GHbA1C, plasma cholesterol and blood pressure were measured prior to the sleep study. Nocturnal TcCO2 features were the most important predictors of lipoprotein cholesterols, triglycerides and blood pressure levels. A longer sleep period and higher TcCO2 levels were linked with lower GHbA1C, and fragmented sleep with lower high-density lipoprotein cholesterol. Neither nocturnal Sa,O2 indices nor the apnoea/hypopnoea index had a predictive power. The results suggest that nocturnal TcCO2 events revealed metabolic risk factors already present in healthy post-menopausal females.

[1]  Diana Gaitini,et al.  Impaired cerebral CO2 vasoreactivity: association with endothelial dysfunction. , 2006, American journal of physiology. Heart and circulatory physiology.

[2]  T. Young,et al.  Sleep fragmentation, awake blood pressure, and sleep-disordered breathing in a population-based study. , 2000, American journal of respiratory and critical care medicine.

[3]  R. Ariagno,et al.  Noninvasive assessment of blood gases. , 1992, The American review of respiratory disease.

[4]  T. Vahlberg,et al.  Reimbursed drugs in patients with sleep-disordered breathing: A static-charge-sensitive bed study. , 2010, Sleep medicine.

[5]  E. Bixler,et al.  Prevalence of sleep-disordered breathing in women: effects of gender. , 2001, American journal of respiratory and critical care medicine.

[6]  F. García-Río,et al.  Sleep apnea and hypertension. , 2000, Chest.

[7]  J. Reckelhoff,et al.  Novel mechanisms responsible for postmenopausal hypertension. , 2004, Hypertension.

[8]  A. Rechtschaffen,et al.  A manual of standardized terminology, technique and scoring system for sleep stages of human subjects , 1968 .

[9]  E. Wolpert.  A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. , 1969 .

[10]  Mats Gyllenberg,et al.  Overnight features of transcutaneous carbon dioxide measurement as predictors of metabolic status , 2008, Artif. Intell. Medicine.

[11]  S. Frontoni,et al.  Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[12]  G. Hamilton,et al.  Obstructive sleep apnoea and cardiovascular disease , 2004, Internal medicine journal.

[13]  Steven B. Heymsfield,et al.  Short Sleep Duration as a Risk Factor for Hypertension: Analyses of the First National Health and Nutrition Examination Survey , 2006, Hypertension.

[14]  S. Jones.  Slow-wave sleep and the risk of type 2 diabetes in humans , 2009 .

[15]  T. Åkerstedt,et al.  Microarousals During Sleep Are Associated With Increased Levels of Lipids, Cortisol, and Blood Pressure , 2004, Psychosomatic Medicine.

[16]  C. Guilleminault,et al.  EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. , 1992, Sleep.

[17]  D. Colquhoun.  Management of hypercholesterolaemia in postmenopausal women , 1989, The Medical journal of Australia.

[18]  Rachel Leproult,et al.  Slow-wave sleep and the risk of type 2 diabetes in humans , 2008, Proceedings of the National Academy of Sciences.

[19]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[20]  A. Scuteri,et al.  End tidal CO2 is an independent determinant of systolic blood pressure in women. , 1999, Journal of hypertension.

[21]  Terry Young,et al.  Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. , 2003, American journal of respiratory and critical care medicine.

[22]  K. Spiegel,et al.  Impact of sleep debt on metabolic and endocrine function , 1999, The Lancet.

[23]  Tero Aittokallio,et al.  Non-invasive respiratory monitoring during wakefulness and sleep in pre- and postmenopausal women , 2006, Respiratory Physiology & Neurobiology.

[24]  A. Chesson,et al.  The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications , 2007 .

[25]  E. Salpeter,et al.  Meta‐analysis: effect of hormone‐replacement therapy on components of the metabolic syndrome in postmenopausal women , 2006, Diabetes, obesity & metabolism.

[26]  K M Hla,et al.  Sleep Apnea and Hypertension: A Population-based Study , 1994, Annals of Internal Medicine.

[27]  J. Greenfield,et al.  Insulin resistance and obesity , 2004, International Journal of Obesity.

[28]  Steven B Heymsfield,et al.  Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. , 2005, Sleep.

[29]  E. Perrin,et al.  Is continuous transcutaneous monitoring of PCO2 (TcPCO2) over 8 h reliable in adults? , 2001, Respiratory medicine.

[30]  A. Chesson,et al.  The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Techinical Specifications , 2007 .

[31]  K. Lam,et al.  Obstructive sleep apnea is independently associated with insulin resistance. , 2002, American journal of respiratory and critical care medicine.

[32]  D. Lübbers.  Theoretical basis of the transcutaneous blood gas measurements , 1981, Critical care medicine.

[33]  E. Bixler,et al.  Sleep apnea is a manifestation of the metabolic syndrome. , 2005, Sleep medicine reviews.

[34]  Tero Aittokallio,et al.  Overnight variability in transcutaneous carbon dioxide predicts vascular impairment in women , 2008, Experimental physiology.

[35]  Andrew G Rundle,et al.  Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. , 2007, Sleep.

[36]  B. Sanner,et al.  Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels , 2006, European Respiratory Journal.

[37]  T. Aittokallio,et al.  Nocturnal transcutaneous carbon dioxide tension in postmenopausal estrogen users and non-users , 2009, Menopause international.

[38]  Thoralf M. Sundt,et al.  The effect of carbon dioxide on the diameter of brain capillaries , 1990, Brain Research.

[39]  J. Skatrud,et al.  Daytime blood pressure elevation after nocturnal hypoxia. , 1999, Journal of applied physiology.

[40]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.